<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02813980</url>
  </required_header>
  <id_info>
    <org_study_id>15-001421</org_study_id>
    <nct_id>NCT02813980</nct_id>
  </id_info>
  <brief_title>Neural Circulatory Control and SUDEP Risk.</brief_title>
  <acronym>NC-SUDEP</acronym>
  <official_title>Neural Circulatory and Respiratory Control in Patients With Epilepsy and the Risk of Sudden Unexpected Death.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Heart Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators believe epilepsy alters the way the body controls blood pressure, heart
      rate and breathing, and these changes increase the risk of sudden unexpected death in
      patients with epilepsy (SUDEP). SUDEP-7 is a risk scoring tool which may correlate with these
      changes to the heart and blood vessels. This research study measures those differences which
      may help identify new markers to help predict those patients at greatest risk in the future.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators overall goals are to determine whether measures of neural-circulatory
      control during the interictal waking and sleep states, as well as during the ictal/peri-ictal
      periods, are associated with SUDEP-7 score risk profiles in refractory epilepsy patients, and
      to translate these measures into tools for risk-stratification and preventative strategies
      for SUDEP.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Abnormal neural circulatory control in patients with epilepsy and high SUDEP-7 scores compared to patients with epilepsy and low SUDEP-7 scores.</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Abnormal neural and respiratory control in the ictal and peri-ictal phase of patients with epilepsy and a high SUDEP-7 score when compared to patients with epilepsy and a low SUDEP-7 score.</measure>
    <time_frame>3-7 days</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Epilepsy</condition>
  <condition>Seizures</condition>
  <arm_group>
    <arm_group_label>High SUDEP-7 score</arm_group_label>
    <description>Patients with epilepsy who have a high SUDEP-7 score</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low SUDEP-7 score</arm_group_label>
    <description>Patients with epilepsy who have a low SUDEP-7 score</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>There are no interventions. This is a prospective observational study.</intervention_name>
    <arm_group_label>High SUDEP-7 score</arm_group_label>
    <arm_group_label>Low SUDEP-7 score</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum and plasma to be stored for future biomarker based studies.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with epilepsy.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults aged 18-50

          -  Able to consent

        Exclusion Criteria:

          -  History of non-epileptic spells/seizures,

          -  Children/adolescents under age 18 years

          -  Pregnancy

          -  Non-compliance with Epilepsy Monitoring Unit safety procedures

          -  Unable to consent

          -  History of dysautonomia

          -  Chronic Obstructive Pulmonary Disease (COPD)

          -  Asthma (active requiring therapy)

          -  Pulmonary hypertension

          -  Known Structural Heart Disease

          -  Heart failure

          -  Myocardial infarction

          -  Stroke

          -  Seizures due to traumatic injury

          -  Prior surgery for epilepsy

          -  Vasculitis

          -  Raynaud's

          -  Smoking (current or within the last 6 months)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Virend K Somers, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lisa D. Block</last_name>
    <phone>507 255 0492</phone>
    <email>CPL@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Somers CPL Lab</last_name>
    <email>CPL@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Erik K St. Louis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anwar A Chahal, MD MRCP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael J Ackerman, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter A Brady, MD FRCP FHRS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 22, 2016</study_first_submitted>
  <study_first_submitted_qc>June 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2016</study_first_posted>
  <last_update_submitted>March 5, 2018</last_update_submitted>
  <last_update_submitted_qc>March 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Virend Somers</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>SUDEP</keyword>
  <keyword>Sudden cardiac death</keyword>
  <keyword>Sudden unexpected death in epilepsy</keyword>
  <keyword>Sleep</keyword>
  <keyword>Polysomnography</keyword>
  <keyword>Autonomic</keyword>
  <keyword>Cardiovascular</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Seizures</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

